The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4725-4736

  Pincetic, Andrew ^a   Kuang, Zhizhou ^a   Seo, Eun Joo ^a   Leis, Jonathan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; INTERFERON; INTERFERON STIMULATED GENE 15; NUCLEIC ACID BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; AVIAN LEUKOSIS ONCOVIRUS; CELL BUDDING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; VIRUS LIKE AGENT; VIRUS MUTATION;

ADENOSINE TRIPHOSPHATASES; AVIAN SARCOMA VIRUSES; CELL LINE; CYTOKINES; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FIBROBLASTS; HIV-1; HUMANS; INTERFERONS; UBIQUITINS; VIRUS RELEASE;

AVES; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77950839509     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02478-09     Document Type: Article

References (54)

1. Agromayor, M., J. G. Carlton, J. P. Phelan, D. R. Matthews, L. M. Carlin, S. Ameer-Beg, K. Bowers, and J. Martin-Serrano. 2009. Essential role of hIST1 in cytokinesis. Mol. Biol. Cell 20:1374-1387.
2. Arguello, M. D., and J. Hiscott. 2007. Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host Microbe 2:367-369.
3. Azmi, I. F., B. A. Davies, J. Xiao, M. Babst, Z. Xu, and D. J. Katzmann. 2008. ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Dev. Cell 14:50-61.
4. Bajorek, M., E. Morita, J. J. Skalicky, S. G. Morham, M. Babst, and W. Sundquist. 2009. Biochemical analyses of human IST1 and its function in cytokinesis. Mol. Biol. Cell 20:1360-1373.
5. Chang, Y.-G., X.-Z. Yan, Y.-Y. Xie, X.-C. Gao, A.-X. Song, D.-E. Zhang, and H.-Y. Hu. 2008. Different roles for two ubiquitin-like domains of ISG15 in protein modification. J. Biol. Chem. 283:13370-13377.
6. Dao, C. T., and D. E. Zhang. 2005. ISG15: a ubiquitin-like enigma. Front. Biosci. 10:2701-2722.
7. Demirov, D. G., and E. O. Freed. 2004. Retrovirus budding. Virus Res. 106:87-102.
8. Dimaano, C., C. B. Jones, A. Hanono, M. Curtiss, and M. Babst. 2008. Ist1 regulates Vps4 localization and assembly. Mol. Biol. Cell 19:465-474.
9. Frias-Staheli, N., N. V. Giannakopoulos, M. Kikkert, S. L. Taylor, A. Bridgen, J. Paragas, J. A. Richt, R. R. Rowland, C. S. Schmaljohn, D. J. Lenschow, E. J. Snijder, A. García-Sastre, and H. W. Virgin IV. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2:404-416.
10. Garrus, J. E., U. K. von Schwedler, O. W. Pornillos, S. G. Morham, K. H. Zavitz, H. E. Wang, D. A. Wettstein, K. M. Stray, M. Cote, R. L. Rich, D. G. Myszka, and W. I. Sundquist. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65.
11. Giannakopoulos, N. V., E. Arutyunova, C. Lai, D. J. Lenschow, A. L. Haas, and H. W. Virgin. 2009. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J. Virol. 83:1602-1610.
12. Gottwein, E., S. Jager, A. Habermann, and H.-G. Krausslich. 2006. Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 Gag cause a late budding defect. J. Virol. 80:6267-6275.
13. Hurley, J. H. 2008. ESCRT complexes and the biogenesis of multivesicular bodies. 20:4-11.
14. Joshi, A., U. Munshi, S. D. Ablan, K. Nagashima, and E. O. Freed. 2008. Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic 9:1972-1983.
15. Kikonyogo, A., F. Bouamr, M. Vana, Y. Xiang, A. Aiyar, C. Carter, and J. Leis. 2001. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells. Proc. Natl. Acad. Sci. U. S. A. 98:11199-11204.
16. Kunzi, M. S., and P. M. Pitha. 1996. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunode-ficiency virus replication. J. Interferon Cytokine Res. 16:919-927.
17. Lenschow, D. J., N. V. Giannakopoulos, L. J. Gunn, C. Johnston, A. K. O'Guin, R. E. Schmidt, B. Levine, and H. W. Virgin. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79:13974-13983.
18. Lenschow, D. J., C. Lai, N. Frias-Staheli, N. V. Giannakopoulos, A. Lutz, T. Wolff, A. Osiak, B. Levine, R. E. Schmidt, A. Garcã-a-Sastre, D. A. Leib, A. Pekosz, K.-P. Knobeloch, I. Horak, and H. W. Virgin. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U. S. A. 104:1371-1376.
19. Loeb, K., and A. Haas. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267:7806-7813.
20. Malakhova, O., and D. Zhang. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283:8783-8787.
21. Martin-Serrano, J., T. Zang, and P. D. Bieniasz. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:1313-1319.
22. Martin-Serrano, J. 2007. The role of ubiquitin in retroviral egress. Traffic 8:1297-1303.
23. Medina, G., Y. Zhang, Y. Tang, E. Gottwein, M. L. Vana, F. Bouamr, J. Leis, and C. Carter. 2005. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 6:880-894. (Pubitemid 41309397)
24. Medina, G., A. Pincetic, Y. Zhang, L. S. Ehrlich, Y. Tang, J. Leis, and C. Carter. 2008. Tsg101 can replace Nedd4 function in ASLV Gag release but not membrane targeting. Virology 377:30-38. (Pubitemid 351799835)
25. Okumura, A., G. Lu, I. Pitha-Rowe, and P. M. Pitha. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103:1440-1445.
26. Okumura, A., P. M. Pitha, and R. N. Harty. 2008. ISG15 inhibits Ebola VP40 budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U. S. A. 105:3974-3979.
27. Ott, D. E., L. V. Coren, R. C. Sowder II, J. Adams, and U. Schubert. 2003. Retroviruses have differing requirements for proteasome function in the budding process. J. Virol. 77:3384-3393.
28. Patnaik, A., V. Chau, and J. W. Wills. 2000. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. U. S. A. 97:13069-13074.
29. Pawliczek, T., and C. Crump. 2009. Herpes Simplex Virus type 1 production requires a functional ESCRT-III complex but is independent of Tsg101 and Alix expression. J. Virol. 83:11254-11264.
30. Pincetic, A., G. Medina, C. Carter, and J. Leis. 2008. Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. J. Biol. Chem. 283:29822-29830.
31. Pincetic, A., and J. Leis. 2009. The mechanism of budding of retroviruses from cell membranes. Adv. Virol. 2009:623969.
32. Pitha-Rowe, I. F., and P. M. Pitha. 2007. Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine Growth Factor Rev. 18:409-417.
33. Pornillos, O., S. L. Alam, R. L. Rich, D. G. Myszka, D. R. Davis, and W. I. Sundquist. 2002. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21:2397-2406. (Pubitemid 34546712)
34. Rue, S. M., S. Mattei, S. Saksena, and S. D. Emr. 2008. Novel Ist1-Did2 complex functions at a late step in multivesicular body sorting. Mol. Biol. Cell 19:475-484.
35. Sadler, A. J., and B. R. G. Williams. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
36. Saksena, S., J. Sun, T. Chu, and S. D. Emr. 2007. ESCRTing proteins in the endocytic pathway. Trends Biochem. Sci. 32:561-573.
37. Sarkar, S. N., and G. C. Sen. 2004. Novel functions of proteins encoded by viral stress-inducible genes. Pharmacol. Ther. 103:245-259.
38. Schmitt, A., G. Leser, D. Waning, and R. Lamb. 2002. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J. Virol. 76:3952-3964. (Pubitemid 34250560)
39. Schmitt, A., G. Leser, E. Morita, W. Sunquist, and R. Lamb. 2005. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J. Virol. 79:2988-2997. (Pubitemid 40270578)
40. Schubert, U., D. E. Ott, E. N. Chertova, R. Welker, U. Tessmer, M. F. Princiotta, J. R. Bennink, H. G. Krausslich, and J. W. Yewdell. 2000. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U. S. A. 97:13057-13062.
41. Shim, S., S. A. Merrill, and P. I. Hanson. 2008. Novel Interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Mol. Biol. Cell 19:2661-2672.
42. Sundquist, W. I., H. L. Schubert, B. N. Kelly, G. C. Hill, J. M. Holton, and C. P. Hill. 2004. Ubiquitin recognition by the human Tsg101 protein. Mol. Cell 13:783-789.
43. Takeuchi, T., and H. Yokosawa. 2005. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem. Biophys. Res. Commun. 336:9-13.
44. Taylor, G., P. Hanson, and M. Kielian. 2007. Ubiquitin depletion and dominant-negative Vps4 inhibit rhabdovirus budding without affecting alphavirus budding. J. Virol. 81:13631-13639. (Pubitemid 350247856)
45. Timmins, J., G. Schoehn, S. Ricard-Blum, S. Scianimanico, T. Vernet, R. Ruigrok, and W. Weissenhorn. 2003. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326:493-502.
46. Vana, M. L., Y. Tang, A. Chen, G. Medina, C. Carter, and J. Leis. 2004. The role of Nedd4 and ubiquitination of RSV Gag in budding of virus-like particles from cells. J. Virol. 78:13943-13953.
47. VerPlank, L., B. Agresta, T. Grassa, A. Kikonyogo, J. Leis, and C. Carter. 2001. Tsg101, the prototype of a class of dominant-negative ubiquitin regulators, binds human immunodeficiency virus type 1 Pr55Gag: the L domain is a determining of binding. Proc. Natl. Acad. Sci. U. S. A. 98:7724-7729.
48. Ward, D. M., M. B. Vaughn, S. L. Shiflett, P. L. White, A. L. Pollock, J. Hill, R. Schnegelberger, W. I. Sundquist, and J. Kaplan. 2005. The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J. Biol. Chem. 280:10548-10555.
49. Wills, J., C. Cameron, C. Wilson, Y. Xiang, R. Bennett, and J. Leis. 1994. An assembly domain of Rous sarcoma virus Gag protein required late in budding. J. Virol. 68:6605-6618. (Pubitemid 24294911)
50. Xiang, Y., C. Cameron, J. Wills, and J. Leis. 1996. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 70:5695-5700. (Pubitemid 26240754)
51. Xiao, J., H. Xia, J. Zhou, I. F. Azmi, B. A. Davies, D. J. Katzmann, and Z. Xu. 2008. Structural basis of Vta1 function in the multivesicular body sorting pathway. Dev. Cell 14:37-49.
52. Yuan, W., and R. M. Krug. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-371.
53. Zhao, C., C. Denison, J. M. Huibregtse, S. Gygi, and R. M. Krug. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 102:10200-10205.
54. Zou, W., V. Papov, O. Malakhova, K. I. Kim, C. Dao, J. Li, and D.-E. Zhang. 2005. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem. Biophys. Res. Commun. 336:61-68.